Ginecología y Obstetricia - Vol. 43 Nº 1 Abril 1997

 

Referencias bibliográficas


1. De Blanco M, Bruce E, Bossemeyer R. Terapia de reemplazo hormonal. XIV Congreso Mundial sobre Fertilidad y Esterilidad. Wyeth Ayerst Internacional, Inc. EE. UU. 1993.

2. Dolan W, Gifford R, Beljan J, et al. Estrogen replacement in the menopause. JAMA 1983; 249: 359-61.

3. Lufkin E, Carpenter P, Ory S, et al. Estrogen replacement therapy: current recommendations. Mayo Clinic Proc 1988; 63: 453-60.

4. Belchetz P. Hormonal treatment of postmenopausal women. N Engl J Med 1991; 330 (15): 1062-71.

5. Pacheco J. Manejo actual del climaterio y la menopausia medicina al día 1993; 2: 25-31.

6. Vassilopoulou R, Zolinski C. Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes. Am J Med Sci 1992; 304 (3): 145-9.

7. Pacheco J. Climaterio y menopausia. Ginecol Obstet Peru 1994; 40: 6-25.

8. Baurer D, Browner W, Cauleyj, et al. Factors associated to bone mass in advanced age women limbs. Ann int med 1993; 118: 657-65.

9. Calderón R. Impacto cardiovascular del climaterio. Ginecol Obstet Peru 1994; 40: 28-30.

10. Matthews K, Meilahn P, Kuller L, et al. Menopause and risks factors for coronary heart disease. N Engl J Med 1989; 321: 641-6.

11. Cummings S. Should perimenopausal women be screened for osteoporisis? Ann Int med 1986; 104: 817-23.

12. Gambacciani M, Spinetti A, De Simone L, et al. Las contribuciones relativas de la menopausia envejecimiento a la osteopenia vertebral postmenopáusica. Menopause digest 1994; 4: 17-20.

13. Christiansen C. The different routes of administration and the effect of hormone replacement therapy on osteoporosis. Fertil Steril 1994; 62: 152s-6s.

14. Hammond C. Women's concerns with hormone replacement therapy - compliance issues. Fertil Steril 1994; 62: 157s-60s.

15. INEI. República del Perú. Censo nacional de población y vivienda. 1993; pág.11-48.

16. Sinclair H, Bond C, Taylor R. Hormone replacement therapy: a study of women's knowledge and attitudes. Brit J Gen Pract 1993; 43 (374): 365-70.

17. Hulka B. Links between hormone replacement therapy and neoplasia. Fertil Steril 1994; 62: 168s-75s.

18. Lobo R, Speroff L. International consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertil Steril 1991; 62: 176s-80s.

19. Blumel J, conocimientos y creencias del efecto de la menopausia y de la terapia estrogénica sobre la salud: estudio en mujeres beneficiarias del hospital barros lucotrudeau. Rev Chil Obstet Ginecol 1994; 59(1):10-6.

20. Von-Muhlen D. A community based study of menopause symptoms and estrogen replacement in older women. Maturitas 1995; 22(2): 71-8.

21. Cano A. Compliance to hormone replacement therapy in menopausal women controlled in third level academic center. Maturistas 1994; 20: 91-9.

22. Collins A. Reproductive health, use of estrogen and experence of symptoms in perimenopausal women: a population-based study. Maturitas 1994; 20: 101-11.

23. Palinkas L. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80(1): 30-6.

24. Fischer S. Tratamiento hormonal en la menopausia. Bol Hosp Viña del Mar 1989; 45: 39-42.

25. Charles A. Tratamientos de suplencia estrogénica después de la menopausia. Trib Med. (Bogotá) 1989; 80(6): 291-3.

26. Haines C. The perception of the menopause and the climacteric among women in Hong Kong and southern China. Rev Med 1995; 24(3): 245-8.

27. Hunter M. Intentions to use hormone replacement therapy in a community sample of 45-year-old women. Maturitas 1994; 20(1): 13-23.

28. Garton M. The climacteric, osteoporosis and hormone replacement; views of women aged 45-49. Maturitas 1995.

29. Abraham S. Australian women's perceptions of hormone replacement therapy over 10 years. Maturitas 1995; 21: 91-95.

 

Regresar al Artículo